SANUWAVE Health (SNWV) Total Debt Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -0.07% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.11% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 1.72% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.34% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -14.39% |
| 10 | SANUWAVE Health | 137.37 Mn | 126.59 Mn | 7.43 Mn | 9.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.92% |
| Dec 31, 2025 | 13.91% |
| Sep 30, 2025 | -62.85% |
| Jun 30, 2025 | 26.92% |
| Mar 31, 2025 | 27.03% |
| Sep 30, 2024 | 25.69% |
| Jun 30, 2024 | 24.49% |
| Mar 31, 2024 | 16.58% |
| Dec 31, 2023 | 19.10% |
| Sep 30, 2023 | 19.09% |
| Jun 30, 2023 | 317.12% |
| Mar 31, 2023 | 878.63% |
| Sep 30, 2022 | 492.43% |
| Jun 30, 2022 | 384.96% |
| Mar 31, 2022 | 361.45% |
| Dec 31, 2021 | 67.48% |
| Sep 30, 2021 | 226.59% |
| Jun 30, 2021 | 338.51% |
| Mar 31, 2021 | 898.22% |
| Dec 31, 2020 | 187.43% |
| Sep 30, 2020 | 140.44% |
| Jun 30, 2020 | -19.23% |
| Mar 31, 2020 | -45.71% |
| Mar 31, 2019 | -71.10% |
| Dec 31, 2018 | -20.85% |
| Sep 30, 2018 | -59.57% |
| Jun 30, 2018 | -70.01% |
| Mar 31, 2018 | -86.93% |
| Dec 31, 2017 | -56.07% |
| Jun 30, 2017 | -57.18% |
| Mar 31, 2017 | -73.50% |
| Dec 31, 2016 | 0.24% |
| Mar 31, 2016 | -21.60% |
| Dec 31, 2015 | -2.73% |
| Sep 30, 2015 | -0.19% |
| Jun 30, 2015 | -0.22% |
| Mar 31, 2015 | 0.00% |
| Dec 31, 2014 | 0.00% |
| Jun 30, 2014 | 0.00% |
| Dec 31, 2013 | 0.00% |